May 1, 2026 03:15PM
Apr 2, 2026 04:05PM
Apr 2, 2026 04:05PM
Apr 2, 2026 04:00PM
Apr 2, 2026 04:00PM
Mar 3, 2026 06:00AM
Mar 3, 2026 06:00AM Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
Nov 3, 2025 08:00AM
May 20, 2025 08:00AM
Nov 4, 2024 08:00AM
May 23, 2024 09:00AM
Jan 23, 2024 04:00PM
Jan 19, 2024 04:49AM
Jan 18, 2024 09:15PM Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock
Jan 18, 2024 04:00PM
Jan 18, 2024 04:00PM
Oct 31, 2023 08:00AM
May 24, 2023 08:00AM
Feb 24, 2023 11:34AM
Feb 24, 2023 09:20AM
Nov 2, 2022 08:00AM Esperion to Participate in Jefferies London Healthcare Conference
Nov 2, 2022 08:00AM
Jun 2, 2022 08:00AM
Jun 2, 2022 08:00AM
May 24, 2021 08:00AM
May 24, 2021 08:00AM
May 5, 2021 09:30AM
Feb 12, 2021 07:58AM UPDATE: Jefferies Downgrades Esperion Therapeutics (ESPR) to Hold
Jan 29, 2021 08:43AM
Oct 27, 2020 08:00AM
Oct 27, 2020 08:00AM
May 27, 2020 08:00AM
May 27, 2020 08:00AM
May 28, 2019 07:00AM
May 28, 2019 07:00AM Esperion to Participate in Upcoming Investor Conferences
Nov 8, 2018 08:00AM
Nov 8, 2018 08:00AM
Jul 10, 2018 01:44PM
May 30, 2018 09:00AM
May 30, 2018 09:00AM
Nov 13, 2017 04:30PM
Aug 21, 2017 08:22AM Esperion Therapeutics (ESPR): Solid set-up into '18 - Jefferies
Aug 10, 2017 05:53AM
Aug 9, 2017 09:20PM
Aug 9, 2017 06:56AM
Aug 8, 2017 04:32PM
Aug 8, 2017 04:32PM
Jul 10, 2017 04:27PM
May 31, 2017 04:30PM Esperion to Present at the Jefferies 2017 Global Healthcare Conference
Mar 21, 2017 09:27AM

72,201 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All